|Videos|November 17, 2021

Pharmacist Medication Insights: Hizentra for Primary Immunodeficiency

Hizentra is indicated for the treatment of primary immunodeficiency in adults and pediatric patients 2 years of age and older and maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy.

Hizentra is an immune globulin subcutaneous (Human) (IGSC), 20%. It is indicated for the treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older and maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

In-Person + Virtual Event

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

December 8, 2025 | 11:30 AM - 1:00 PM PT

Webinar Registration

The Educated Pharmacist: Overcoming Clinical Inertia - An Interactive Case Workshop for Optimizing Insulin Use

December 10, 2025 | 11:30 AM - 1:00 PM PT

Satellite Symposia

ASHP Midyear 2025

December 8-10, 2025

Panel Discussion Registration

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

December 10, 2025 | 1:00 PM - 2:30 PM ET

$Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists$

Webinar Registration

Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists

Thursday, December 11, 2025 | 1:00 PM & 8:00 PM EST

Pharmacist Medication Insights: Hizentra for Primary Immunodeficiency

Newsletter

Related Content

MRD, ctDNA Testing May Help Diagnose Multiple Myeloma Precursor Conditions

Longevity Medicine: Just Another Reincarnation of Diet and Exercise or Something Altogether Different?

CGMs That Measure Alternative Biofluids Show Potential in Diabetes Care

Training for the Floor: How Pharmacists Prepare for Unit-Based Practice

The Operational Hurdles Behind Unit-Based Pharmacy

Latest CME

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

The Educated Pharmacist: Overcoming Clinical Inertia - An Interactive Case Workshop for Optimizing Insulin Use

ASHP Midyear 2025

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists

The Evolving Treatment Landscape of Migraine

HER2 in Focus: Biomarker Insights and Therapeutic Advancements Across Solid Tumors

Targeting the Complement Cascade: Evolving Strategies in the Management of Complement-Mediated Kidney Diseases

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma

Advancing HER2-Driven Cancer Care, Biomarker Testing, and Pharmacist Innovation

Navigating Diabetes: A Guide to Effective Oral Treatments

Beyond the Spots: Management of Measles

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Tracking a Moving Target in HR+ Metastatic Breast Cancer: Innovative Oral Therapies and Evolving Strategies

Transforming Lymphoma Treatment With Bispecific Antibodies: Practical Solutions for Oncology Pharmacy Teams

Advancing Care in HER2-Negative Early Breast Cancer: Essential Insights and Best Practices for Oncology Pharmacists

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Navigating the World of Insulin: An Update on Types, Uses, and Considerations

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

JAK(i) of All Trades: Navigating Myelofibrosis Treatment and Safety in Community Oncology Practice

Beyond Chimeric Antigen Receptor T-Cell Therapy: Comprehensive Approaches for Community Oncology Practices in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Aiming for Accuracy in Non-Small Cell Lung Cancer Treatment: Precision Strategies for Oncology Pharmacists

Advancing Chronic Lymphocytic Leukemia Treatment in the Community: Practical Updates and Clinical Pearls for Oncology Pharmacists

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Shaping the Future of Renal Cell Carcinoma: A Case-Based Exploration of Emerging Treatment and Improved Patient Outcomes

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring

A Deep Dive Into CGM Data (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025? (Pharmacy Technician)

A Deep Dive Into CGM Data

Improving the Care of Persons Living With Diabetes Using CGM Devices (Pharmacy Technician Credit)

Mastering Hyperlipidemia Management: Enhancing Adherence and Expanding Nonstatin Therapy Options

Beyond the Prescription: Tackling Social Isolation for Better Health

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases

Evaluating the Role of Pharmacists in Utilizing Potassium-Competitive Acid Blockers for Acid Peptic Disorders

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

Navigating the Complexity of Migraine: A Multimodal Approach to Acute Treatment

Iron Deficiency Anemia Treatment Considerations in Women’s Health

Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene

Personalizing Treatment in Relapsed/Refractory Multiple Myeloma: The Evolving Role of Antibody-Drug Conjugates and Bispecific Antibodies

Adapting to Advances in EGFR-Positive Non-Small Cell Lung Cancer Treatment: Critical Insights for Oncology Pharmacists

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

Expert Insights on the Horizon of HER2-Directed Therapy

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

The Pharmacist's Role in Palliative and End of Life Symptom Management

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies